Feifei Luo

2.7k citations
57 papers · 1.8k · 1 hit paper · h-index 25

Impact in

  • Immunology top 5%
    • Immune cells in cancer
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • Immune Response and Inflammation
  • Oncology top 5%
    • CAR-T cell therapy research
    • Cancer Immunotherapy and Biomarkers

Papers in

    • Immune Cell Function and Interaction 10
    • Immune cells in cancer 10
    • Immunotherapy and Immune Responses 8
    • Immune Response and Inflammation 7
    • CAR-T cell therapy research 9
    • Cancer Immunotherapy and Biomarkers 7

Feifei Luo

54 papers receiving 1.8k citations

Feifei Luo's Hit Papers

Targeting tumor monocyte-intrinsic PD-L1 by rewiring STING signaling and enhancing STING agonist therapy 2025 · 20 citations
200Years since publication5101520

Peers

Feifei Luo
Comparison fields: 5 of 113
  • Immunology 823
  • Oncology 693
  • Cancer Research 252
  • Genetics 178
  • Neurology 95
Replace Marie‐Luise Kruse with:
Marie‐Luise Kruse Germany
Aileen Houston Ireland
Sandrine Marchetti France
Martin R. Jadus United States
Marta Compte Spain
В. М. Писарев Russia
Katharina Detjen Germany
Dong Cheng China
Degao Chen China
Evguenia Strom United States
Feifei Luo relative to Marie‐Luise Kruse Germany Marie‐Luise Kruse's profile →
Citations per field
00.5×11.2×
Marie‐Luise Kruse · 1×
Citations per year

Countries citing papers authored by Feifei Luo

Since Specialization
Citations

This map shows the geographic impact of Feifei Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feifei Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feifei Luo more than expected).

Fields of papers citing papers by Feifei Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Feifei Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feifei Luo. The network helps show where Feifei Luo may publish in the future.

Co-authors

The 25 scholars most cited alongside Feifei Luo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Feifei Luo Line = papers co-authored together Feifei Luo links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 57 papers — load more, or switch the sort, to bring in the rest.

#Work
1 2018207
2 2020123
3 2011100
4 201890
5 201883
6 201878
7 200271
8 201771
9 201967
10 202164
11 201157
12 199654
13 200949
14 201849
15 201547
16 199345
17 201939
18 201137
19 201737
20 202431

About Feifei Luo

Feifei Luo is a scholar working on Immunology, Oncology, Molecular Biology, Genetics and Cancer Research, having authored 57 papers that have together received 1.8k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (10 papers), Immune cells in cancer (10 papers), CAR-T cell therapy research (9 papers), Immunotherapy and Immune Responses (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Immune Response and Inflammation (7 papers), Virus-based gene therapy research (5 papers) and Epigenetics and DNA Methylation (4 papers). The work is most often cited by research in Immunology (823 citations), Oncology (693 citations), Cancer Research (252 citations), Genetics (178 citations) and Neurology (95 citations). Feifei Luo has collaborated with scholars based in China, United States and Belgium. Frequent co-authors include Yiwei Chu, Yuedi Wang, Jiao Yang, Jiawen Qian, Ronghua Liu, Yuting Deng, Chujun Zhao, Luman Wang, Yufei Zhang and Bo Wang. Their work appears in journals such as Frontiers in Immunology, Cancer Immunology Immunotherapy, Journal of Translational Medicine, Proceedings of the National Academy of Sciences and Cellular and Molecular Immunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact